Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Rosenson

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Journal of Endocrinological Investigation|August 2, 2002
Statins and the risk of rhabdomyolysisR S Rosenson
Archives of Internal Medicine|June 24, 1996
Beyond low-density lipoprotein cholesterol. A perspective on low high-density lipoprotein disorders and Lp(a) lipoprotein excessR S Rosenson
The American Journal of Cardiology|February 15, 1993
Gemfibrozil-lovastatin-associated myalgiaR S Rosenson
Journal of the American College of Cardiology|September 1, 1993
Myocardial injury: the acute phase response and lipoprotein metabolismR S Rosenson
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapyR S Rosenson
Current Cardiology Reports|September 12, 2000
Non-lipid-lowering effects of statins on atherosclerosisR S Rosenson
Cardiology in Review|February 24, 2001
Hypertriglyceridemia and coronaryheart disease riskR S Rosenson
Current Opinion in Neurology|March 17, 2000
Biological basis for statin therapy in stroke preventionR S Rosenson
Current Atherosclerosis Reports|December 21, 2000
Basic mechanisms of stroke prevention with lipid-lowering therapyR S Rosenson
Archives of Internal Medicine|July 12, 1993
Low levels of high-density lipoprotein cholesterol (hypoalphalipoproteinemia). An approach to managementR S Rosenson
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Journal of Endocrinological Investigation|August 2, 2002
Statins and the risk of rhabdomyolysisR S Rosenson
Archives of Internal Medicine|June 24, 1996
Beyond low-density lipoprotein cholesterol. A perspective on low high-density lipoprotein disorders and Lp(a) lipoprotein excessR S Rosenson
The American Journal of Cardiology|February 15, 1993
Gemfibrozil-lovastatin-associated myalgiaR S Rosenson
Journal of the American College of Cardiology|September 1, 1993
Myocardial injury: the acute phase response and lipoprotein metabolismR S Rosenson
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapyR S Rosenson
Current Cardiology Reports|September 12, 2000
Non-lipid-lowering effects of statins on atherosclerosisR S Rosenson
Cardiology in Review|February 24, 2001
Hypertriglyceridemia and coronaryheart disease riskR S Rosenson
Current Opinion in Neurology|March 17, 2000
Biological basis for statin therapy in stroke preventionR S Rosenson
Current Atherosclerosis Reports|December 21, 2000
Basic mechanisms of stroke prevention with lipid-lowering therapyR S Rosenson
Archives of Internal Medicine|July 12, 1993
Low levels of high-density lipoprotein cholesterol (hypoalphalipoproteinemia). An approach to managementR S Rosenson
Pageof 7